Nanotechnology and pancreatic cancer management: State of the art and further perspectives
Damiano Caputo, Tommaso Farolfi, Roberto Passa, Roberto Coppola, Department of General Surgery, University Campus Bio-Medico di Roma, Rome 00128, Italy
Daniela Pozzi, Giulio Caracciolo, Department of Molecular Medicine, Sapienza University of Rome, Rome 00161, Italy
Author contributions: Caputo D contributed to conception or design of the work; Farolfi T and Passa R contributed to data collection; Caputo D, Pozzi D and Caracciolo G contributed to data analysis and interpretation; Caputo D and Caracciolo G contributed drafting the article; Caputo D, Pozzi D, Coppola R and Caracciolo G contributed to critical revision of the article; all authors did the final approval of the version to be published.
Conflict-of-interest statement: All Authors declare that they do not have any conflict of interest.
: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Damiano Caputo, FACS, MD, Associate Professor, Surgeon, Department of General Surgery, University Campus Bio-Medico di Roma, Via Álvaro del Portillo, 200, Rome 00128, Italy. email@example.com
Received: January 12, 2021
Peer-review started: January 12, 2021
First decision: February 11, 2021
Revised: February 21, 2021
Accepted: March 12, 2021
Article in press: March 12, 2021
Published online: April 15, 2021